4Ganesh G, Konduri U, Olivia Kim. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn [J] . Pediatric Clinics of North America, 2009, 89 (3) : 579.
6Tissot C, Beghetti M. Review of inhaled iloprost for the control of pulmonary artery hypertension in children [ J ] . Vasc Health Risk Manag, 2009, 5 (1) : 325.
7Kelly LK, Porta NF, Goodman DM et al. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refracto- ry to inhaled nitric oxide [J] . J Pediatr, 2002, 141 (6) : 830.
9Tourneux P, Rakza T, Bouissou A et al. Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pul- monary hypertension[J].J Pediatr, 2008, 153 (3) : 345.
10Cruz - Blanquel A, Espinosa - Oropeza A, Romo - Hem6ndez G et al. Persistent pulmonary hypertension in the newborn: thera- peutic effect of sildenafil [ J ]. Proc West Pharmacol Soc, 21308, 51(8) :73.
二级参考文献7
1Weiberger B,Weiss K,Heck DE,et al.Pharmacologic therapy of persistent pulmonary hypertension of newborn.Pnarmacol Therapy,2001,89:67.
2Colonna F, Giorgi R, Ciana G, et al. Efficacy of magnesium in a case of neonatal pulmonary hypertension refractory to the usual therapies. Minerva, Pediatr, 1994,46:553 - 555.
3Tolsa JF,Cotting J ,Sekarski N ,et al. Magnisium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child, 1995,72 : 184.
7Leuchte HH,Sdwaiblmair M,Baumgartner RA,et al.Hemodynamieresponse to sildenafil,nitricoxide and iloprost in primarypulmonary Hypertension[J].Chest,2004,125(2):580-586.
8Leuchte HH,Sdwaiblmair M,Baumgartner RA, el al. Hemodynanl ier- esponse to sildenafil,nitricoxide and iloprost in primary pulmonary Hy- pertension [ J ]. Chest,2004,125 ( 2 ) :580 - 586.
10Xu XF, Gu WZ, Wu XL, et al.Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin[J].J Matern Fetal Neonatal Med, 2011, 24(1):172-182.
